Thousands of Addicts Face Involuntary Withdrawal
By Prithi Yelaja, CBC News
The move to replace the prescription painkiller OxyContin with a newer formulation less prone to misuse won’t solve the crisis of widespread abuse, experts say, unless there is additional training for physicians and treatment for addicts.
Following a similar move in the U.S. in 2010, Purdue Pharma will stop manufacturing OxyContin in Canada and replace it —starting Thursday — with OxyNeo pills, which have been treated to make them extremely difficult to break down. » More

